2009.05.07 Weekly Broadcast Email
The following updates were made the website for the week of May 4, 2009.
The following adverse event was reported during the month of April. A PDF of the AE document has been attached to this email and a summary of the event can be found on the adverse event page of the website.
98308: AE 21
In the month of April, 15 patients were accrued to CCCWFU CCOP Research Base trials. Wake Forest was the top accruing site with 7 patients. See the Research Base website home page for accrual information on each site.
97106 (Randomized Study to Determine whether ArginMax Improves the Sexual Function and Quality of Life in Female Cancer Survivors) only has 15 minority accrual slots open for patient accruals. We would like to see this study close by the end of the summer, so if you have patients that may be eligible for this study, please try and get them registered by then.
97405 (Randomized Study of Soy Protein and Effexor on Vasomotor Symptoms of Men with Prostate Cancer)
Since the closure of the COLD-fX, is your site looking for a new study? Then consider enrolling patients in the Soy/Effexor trial.
Our goal is to have 125 patients registered by June 1st. Click here to download the protocol documents, view slide show presentations, and more. Consider joining the Research Base in reaching its June 1st goal!